LETTERS FOR ISSUE ON

Similar documents
LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

TODAY LETTER DATED

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division

RESULTS AND DISCUSSION

Recommendations of thesec (Dermatology & Allergy) made in its 23 rd meeting held on at CDSCO HQ New Delhi: New Drugs Division

3. Dr.Rajutitus Chacko, Prof. & Head, Dept. of Medical Oncology, CMC, Vellore.

Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33

REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA

New Delhi, the 18 th December, 2017 ORDER

Education. Current Activities

10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE

ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet

Subsequent New Drugs Division. M/s.Troikaa. M/s. Olive Healthcare. Biological Division. M/s. Wockhardt Ltd. Global Clinical Trial Division

TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No.

BRIC DIABETES DRUGS MARKET

Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet

CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...

Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:-

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)

TRADE MARKS REGISTRY AHMEDABAD

Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013

Recommendations: Agend a no. Recommendations. Institute. New Drugs Division /12-DC ArbekacinSulphate Injection 200mg/4ml

GLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS

Name of firm/applicant. Torrent Pharmaceuticals. Glenmark Pharmaceuticals. M/s. Torrent Pharmaceutical. Torrent Pharmaceuticals

New Drugs Division. Frequently Asked Questions (FAQs) on Approval of new Phytopharmaceutical Drugs

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage

DR. P. V. APPAJI M.Pharm, Ph.D EXECUTIVE DIRECTOR

Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES

AGENDA PAPERS FOR THE EIGHTEENTH MEETING SUB-COMMITTEE ON LARGE ANIMALS (SCLA)

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.

M/s. Hetero Labs Ltd.

Organ Transplantation Market Research Report- Global Forecast Till 2023

TRADE MARKS REGISTRY AHMEDABAD

Regulatory Reforms-Future of Plasma Protein Therapy in India

Ameya works predominantly in the architectural design, interiors and project management segments in healthcare industry

Vascular Endothelial Growth Factor Inhibitor Market

Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic

Name of firm/applicant

SAMPLE. Asia-Pacific Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central Venous

Exhibitor Prospectus

Dataset : PharmaTrac MAT MAY PharmaTrac Overview MAY 18

Solvay in India January, 2014

III) Firms which attended the pre bid conference are as follows: M/s Becton Dickinson India Pvt. Ltd., Gurgaon

What s New

Merriman Investment Summit 2009

Information for Vermont Prescribers of Prescription Drugs

PDF of Trial CTRI Website URL -

REF/2016/08/ CTRI Website URL -

Country Coverage. Company Coverage

Oncology Pipeline Analytics

Study of Physicochemical Compatibility of Inhalation Grade Active Ingredients with Propellant HFA 134a by FTIR

Global Aspergillosis Drugs Market Professional Survey Report 2016

14 th SEC- Gastroenterology& Hepatology held on at CDSCO (HQ), FDA Bhawan, Kotla road, NewDelhi

Companies Database, Mobile Database, Id Database, Credit

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet

Patel Krunal M et al. IRJP 2 (2)

Law Relating to. Drugs and Cosmetics. containing. Drugs and Cosmetics Act, 1940 Drugs and Cosmetics Rules, 1945

Approved L1 rates and tenderers for 162 Speciality drugs for the year

CURRICULUM VITAE Intern in Medicine, Beth Israel Hospital, Harvard Medical School, Boston, MA

REF/2012/08/ CTRI Website URL -

Partial Table of Contents (Contact Client Services to receive complete Table of Contents) IV. Design Criteria for Decentralized Testing Products

Antifungal Drugs Market by Drug Type [Echinocandins {Caspofungin, Micafungin, Anidulafungin and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles

Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL -

Sample Pages. Needlestick Safety Injection Devices Market, Copyright 2012 Banyan Wharf Consultants Ltd. Page 1

Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016

PDF of Trial CTRI Website URL -

A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database

MEETING OF DRUGS TECHNICAL ADVISORY BOARD HELD ON 1 ST APRIL, 2014 IN THE CHAMBER OF DGHS, NIRMAN BHAWAN, NEW DELHI

Partial Table of Contents (Contact Client Services to receive complete Table of Contents) IV. Design Criteria for Decentralized Testing Products

Excipient Regulations Perspective & Creation of IPEC India (Current Regulations & Emerging challenges for excipient regulations in India)

Global Coverage. Regional Coverage. Company Coverage. Country Coverage. Global Coverage Regional Coverage Country Coverage

TABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF

EAPCI: Biodegradable Scaffolds-Writers 2016

Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules

INDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2016 ADMISSION SESSION ROUND-2

(Poster presented on Sunday 05 March, 08:50 08:55; 2017 AAD Meeting, Orlando, Florida, USA)

FROST & SULLIVAN. Publications Division - Terms and Conditions of Business

Blood Glucose Test Strip Market Research Report- Global Forecast till 2020

100 Abbott Park Road Abbott Park, IL Trade Name: ARCHITECT HIV Ag/Ab Combo Assay Approved Date: 18-JUN-2010

Transcription:

S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD 6484 APPROVAL M/S BIOCON LTD 6350, 6349, 4832 APPROVAL & CLARIFICATION M/S FERRING PHARMACEUTICALS 7638 APPROVAL M/S GSK 931 ACKNOWLEDGE M/S ABBOTT INDIA LTD 6777 APPROVAL M/S INDOVAX 7428 (FTS NO) APPROVAL M/S JOHNSON & JOHNSON APPROVAL M/S G.C. CHEMIE PHARMIE LTD 15535 (FTS NO) APPROVAL M/S BIOMED 8054 APPROVAL M/S ELI LILLY AND COMPANY INDIA M/S SANOFI SYNTHELABO INDIA PVT, LTD M/S GENNOVA BIOPHARMACEUTICALS LTD 6183 APPROVAL 4738,4739 APPROVAL 11405 (FTS NO) CLARIFICATION GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. NOVARTIS 6163/1591/5578/6162 TL APPROVAL

2 M/S. CLINIRX 1165/607 PA/ SITE APPROVAL S 3 M/S. JSS - MINUTES OF MEETING 4 M/S. IPROCESS 32145/2357 PA / TL APPROVAL S 5 M/S. MAYA CLINICALS 6169 TL APPROVAL 6 M/S. KENDLE 4763 PA/TL APPROVAL S LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 1. M/S. REALCADE LIFESCIENCES PVT. MEHSANA, GUJARAT 6052, 6055, 6053, 6051, 11717, 11718, 11719, 11720, 11722 QUERY COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. AVON BEAUTY PRODUCTS INDIA PVT. GURGAON 4606 APPROVAL 2. M/S. LOTUS HERBALS (P) U.P. 7353 APPROVAL 3. M/S. WIPRO ENTERPRISES PVT. BANGALORE 7592 APPROVAL 4. M/S. PALSON DERMA PVT. KOLKATA 5385 APPROVAL 5. M/S. FACES COSMETICS INDIA PVT. MUMBAI 5978 APPROVAL 6. M/S. SWEETYET DEVELOPMENT DISTRIBUTION INDIA PVT. MUMBAI 6151 APPROVAL FDC DIVISION S.NO. NAME OF COMPANY DIARY NO. DOCUMENT 1. M/S. CENTAUR PHARMACEUTICALS PVT. LTD 2506 2. M/S. ZUVENTUS HEALTHCARE 2393 03 S 3. M/S. SYNOKEM PHARMACEUTICALS 13143 MEDICAL DEVICE

S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. SYNERGY PHARMA FORMULATIONS INDIA PVT. LTD. 13235 CLARIFICATION 2. M/S. GENERAL MEDICAL SYSTEMS PVT. LTD. 5244 CLARIFICATION 3. M/S. EMERGO (INDIA) CONSULTING PVT. LTD. 12383 4. M/S. BAXTER (INDIA) PVT. LTD. NIL 5. M/S. MANJU ENTERPRISES PVT. LTD. ALL PORT OFFICES OF CDSCO 6. M/S. BOSTON SCIENTIFIC INDIA PVT. LTD. ALL PORT OFFICES OF CDSCO 7. M/S. ORTHO LIFE SYSTEMS THE STATE DRUGS CONTROLLER, DELHI NIL NIL FTS. NO.- 11236 8. THE FOREIGN TRADE DEVELOPMENT OFFICER NIL 9. THE COMMISSIONER, GANDHINAGAR (CLAA) THE DEPUTY DRUGS CONTROLLER, AHMEDABAD (CLAA) (M/S. BONETECH MEDISYS PVT. AHMEDABAD) FTS. NO. - 14531 APPROVAL DIAGNOSTICS DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ROCHE DIAGNOSTICS INDIA PVT. LTD. 7476 APPROVAL (TEST LICENSE) 2. M/S. ROCHE DIAGNOSTICS INDIA PVT. LTD. 7473 APPROVAL (TEST LICENSE) 3. M/S. ROCHE DIAGNOSTICS INDIA PVT. LTD. 6448 4. M/S. BECTON DICKINSON INDIA PVT. LTD. 3139 5. M/S. BECKMAN COULTER INDIA PVT. LTD. 6475

6. M/S. KHC HEALTHCARE INDIA PVT. LTD. NIL 7. M/S. SD BIOSENSOR HEALTHCARE PVT. LTD. NIL 8. M/S. SIEMENS HEALTHCARE PVT. LTD. NIL 9. M/S. RELIABLE PRO-DETECTS BIOMEDICAL PVT. LTD. NIL 10. M/S. J. MITRA & CO. PVT. LTD. NIL 11. M/S. BHAT BIO-TECH INDIA(P) LTD. NIL NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. DR. REDDY S LABS - TL, IPC, QUERY 2. M/S. VIJAYASRI ORGANIC - IPC, QUERY 3. M/S. AJANTA PHARMA - IPC (2), 4. M/S. EMCURE PHARMACEUTICALS - QUERY 5. M/S. CIPLA LTD. - QUERY 6. M/S. CADILA HEALTHCARE LTD. MEETING ON 7. M/S. TORRENT PHARMACEUTICALS LTD. MEETING ON 8. M/S. INTAS PHARMACEUTICALS LTD. MEETING ON 9. M/S. SPECTRUM ONCOLOGY PVT MEETING ON 10. M/S. WOCKHARDT MEETING ON 11. M/S. GLENMARK PHARMACEUTICALS MEETING ON SUBSEQUENT NEW DRUG S. NO. NAME OF THE FIRM REFERENCE NO. FTS NO. TYPE OF

1. M/S AJANTA PHARMA LIMITED., 2. M/S NANZ MED SCIENCE PHARMA PVT. 3. M/S DELTECH HEALTHCARE PVT. 4. M/S JOHNSON & JOHNSON 5. M/S MAPS LABORATORIES PRIVATE LIMITED, 6. M/S ASTELLAS PHARMA INDIA PVT. 1023 2289 DEFICIENCY, IPC NOC (2) 3228 6540 DEFICIENCY 2584 - DEFICIENCY 51089 - APPROVAL (2) - 6426 DEFICIENCY, IPC NOC 769 4292 DEFICIENCY